Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.730
-0.030 (-1.70%)
At close: Aug 28, 2026, 4:00 PM EDT
1.710
-0.020 (-1.16%)
After-hours: Aug 28, 2026, 6:58 PM EDT

ZYBT Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
116.36186.36211.65260.27214.07
Revenue Growth
-37.56%-11.95%-18.68%21.58%-
Cost of Revenue
92.4995.0694.14112.3989.45
Gross Profit
23.8791.3117.51147.88124.62
Selling, General & Admin
74.9263.8464.3458.8958.86
Research & Development
18.0112.7911.913.4211.37
Operating Expenses
94.3874.8672.5282.0572.16
Operating Income
-70.5116.4444.9965.8352.47
Interest Expense
-3.4-4.04-4.42-2.84-1.05
Interest & Investment Income
0.10.230.310.110.11
Currency Exchange Gain (Loss)
-0.310.68---
Other Non Operating Income (Expenses)
2.120.882.890.811.62
EBT Excluding Unusual Items
-7214.1943.7663.9153.15
Gain (Loss) on Sale of Investments
0.130.21---
Asset Writedown
-----0.08
Pretax Income
-71.8714.3943.7663.9153.07
Income Tax Expense
11.10.926.258.176.6
Earnings From Continuing Operations
-82.9713.4737.5155.7446.47
Minority Interest in Earnings
13.18-2.16-6.05-9.01-7.51
Net Income
-69.7811.3131.4646.7438.96
Net Income to Common
-69.7811.3131.4646.7438.96
Net Income Growth
--64.04%-32.69%19.96%-
Shares Outstanding (Basic)
4746464646
Shares Outstanding (Diluted)
4746464646
Shares Change
3.69%----
EPS (Basic)
-1.470.250.691.020.85
EPS (Diluted)
-1.470.250.691.020.85
EPS Growth
--64.04%-32.69%19.96%-

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
12.3327.4640.79-9.9912.75
Free Cash Flow Per Share
0.260.600.89-0.220.28
Gross Margin
20.51%48.99%55.52%56.82%58.22%
Operating Margin
-60.59%8.82%21.25%25.30%24.51%
Profit Margin
-59.97%6.07%14.86%17.96%18.20%
Free Cash Flow Margin
10.59%14.74%19.27%-3.84%5.96%
EBITDA
-44.6240.668.984.6368.48
EBITDA Margin
-38.35%21.79%32.55%32.52%31.99%
D&A For EBITDA
25.8824.1623.9118.816.01
EBIT
-70.5116.4444.9965.8352.47
EBIT Margin
-60.59%8.82%21.25%25.29%24.51%
Effective Tax Rate
-6.42%14.29%12.79%12.44%
Advertising Expenses
1.721.542.542.582.23
SEC Filings: 10-K · 10-Q